124 related articles for article (PubMed ID: 17621271)
21. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
[TBL] [Abstract][Full Text] [Related]
22. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas.
Pérot G; Derré J; Coindre JM; Tirode F; Lucchesi C; Mariani O; Gibault L; Guillou L; Terrier P; Aurias A
Cancer Res; 2009 Mar; 69(6):2269-78. PubMed ID: 19276386
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
24. Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown.
Lin FR; Kuo HK; Ying HY; Yang FH; Lin KI
Cancer Res; 2007 Dec; 67(24):11914-23. PubMed ID: 18089822
[TBL] [Abstract][Full Text] [Related]
25. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of the B-cell receptor signaling component CD79b in plasma cell myeloma: a possible post transcriptional regulation.
Huang X; Takata K; Sato Y; Tanaka T; Ichimura K; Tamura M; Oka T; Yoshino T
Pathol Int; 2011 Mar; 61(3):122-9. PubMed ID: 21355953
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
28. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
29. Assignment of the human gene for Oct-binding factor-1 (OBF1), a B-cell-specific coactivator of octamer-binding transcription factors 1 and 2, to 11q23.1 by somatic cell hybridization and in situ hybridization.
Junker S; Brøndum-Nielsen K; Newell JW; Matthias P; Tommerup N
Genomics; 1996 Apr; 33(1):143-5. PubMed ID: 8617501
[No Abstract] [Full Text] [Related]
30. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
[TBL] [Abstract][Full Text] [Related]
31. KLF4 is a FOXO target gene that suppresses B cell proliferation.
Yusuf I; Kharas MG; Chen J; Peralta RQ; Maruniak A; Sareen P; Yang VW; Kaestner KH; Fruman DA
Int Immunol; 2008 May; 20(5):671-81. PubMed ID: 18375530
[TBL] [Abstract][Full Text] [Related]
32. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma.
Sugimoto T; Seki N; Shimizu S; Kikkawa N; Tsukada J; Shimada H; Sasaki K; Hanazawa T; Okamoto Y; Hata A
Genes Chromosomes Cancer; 2009 Feb; 48(2):132-42. PubMed ID: 18973137
[TBL] [Abstract][Full Text] [Related]
33. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
34. Plasma cell differentiation and multiple myeloma.
Shapiro-Shelef M; Calame K
Curr Opin Immunol; 2004 Apr; 16(2):226-34. PubMed ID: 15023417
[TBL] [Abstract][Full Text] [Related]
35. Characterization of in vitro growth of multiple myeloma cells.
Zlei M; Egert S; Wider D; Ihorst G; Wäsch R; Engelhardt M
Exp Hematol; 2007 Oct; 35(10):1550-61. PubMed ID: 17889722
[TBL] [Abstract][Full Text] [Related]
36. A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines.
Khoo SH; Falciani F; Al-Rubeai M
Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):85-95. PubMed ID: 17223793
[TBL] [Abstract][Full Text] [Related]
37. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
Bauer K; Kretzschmar AK; Cvijic H; Blumert C; Löffler D; Brocke-Heidrich K; Schiene-Fischer C; Fischer G; Sinz A; Clevenger CV; Horn F
Oncogene; 2009 Aug; 28(31):2784-95. PubMed ID: 19503092
[TBL] [Abstract][Full Text] [Related]
38. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling defines a high-risk entity of multiple myeloma.
Zhan FH; Barlogie B; John D S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):191-203. PubMed ID: 17478923
[TBL] [Abstract][Full Text] [Related]
40. [The isolation and genetic characteristics of the new cell line of mouse myeloma spEBR-5 selected for ethidium bromide resistance and characterized by multiple drug resistance].
Berezkina EV; Lipskaia LA; Grinchuk TM; Kovaleva ZV; Sorokina EA; Vasiukhin VI; Ignatova TN
Tsitologiia; 1994; 36(7):687-95. PubMed ID: 7900209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
